Welcome to LookChem.com Sign In|Join Free

CAS

  • or

96829-89-9

Post Buying Request

96829-89-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

96829-89-9 Usage

Uses

5-Phenyloxazole-2-carboxaldehyde has been used in the preparation of (diazomethyl)oxazole.

Check Digit Verification of cas no

The CAS Registry Mumber 96829-89-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,8,2 and 9 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 96829-89:
(7*9)+(6*6)+(5*8)+(4*2)+(3*9)+(2*8)+(1*9)=199
199 % 10 = 9
So 96829-89-9 is a valid CAS Registry Number.

96829-89-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Phenyl-1,3-oxazole-2-carbaldehyde

1.2 Other means of identification

Product number -
Other names 5-phenyloxazole-2-carbaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:96829-89-9 SDS

96829-89-9Downstream Products

96829-89-9Relevant articles and documents

URIDINE NUCLEOSIDE DERIVATIVES, COMPOSITIONS AND METHODS OF USE

-

Paragraph 0260, (2018/04/20)

This disclosure relates to uridine nucleoside derivatives, compositions comprising therapeutically effective amounts of those nucleoside derivatives and methods of using those nucleoside derivatives or compositions in treating disorders that are responsive to compounds, such as agonists, of P2Y6 receptor, e.g., neuronal disorders, including neurodegenerative disorders (e.g., Alzheimer's disease, Parkinson's disease) and traumatic CNS injury, pain, Down Syndrome (DS), glaucoma and inflammatory conditions.

INHIBITORS OF HCV NS5B POLYMERASE

-

Page 26, (2010/02/06)

The present invention porivdes compounds of Formula I, compositons and methods that are useful for treating viral infections and associated diseases, particularly HCV infections and associated diseases.

A New Facile Synthesis of 2-Aroyloxazoles from 2-Lithiooxazoles

Pridgen, Lendon N.,Shilcrat, Susan C.

, p. 1048 - 1050 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 96829-89-9